<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-GB">
	<id>https://ltrc.sciwiki.in/index.php?action=history&amp;feed=atom&amp;title=ADB-HEXINACA</id>
	<title>ADB-HEXINACA - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://ltrc.sciwiki.in/index.php?action=history&amp;feed=atom&amp;title=ADB-HEXINACA"/>
	<link rel="alternate" type="text/html" href="https://ltrc.sciwiki.in/index.php?title=ADB-HEXINACA&amp;action=history"/>
	<updated>2026-10-17T18:43:14Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.9</generator>
	<entry>
		<id>https://ltrc.sciwiki.in/index.php?title=ADB-HEXINACA&amp;diff=6450&amp;oldid=prev</id>
		<title>Digantasen: ইংরেজি উইকিপিডিয়ার “ADB-HEXINACA” নিবন্ধের বাংলা অনুবাদ</title>
		<link rel="alternate" type="text/html" href="https://ltrc.sciwiki.in/index.php?title=ADB-HEXINACA&amp;diff=6450&amp;oldid=prev"/>
		<updated>2026-10-15T08:38:12Z</updated>

		<summary type="html">&lt;p&gt;ইংরেজি উইকিপিডিয়ার “ADB-HEXINACA” নিবন্ধের বাংলা অনুবাদ&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[File:ADB-HEXINACA structure.svg|thumb]]&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
! colspan=&amp;quot;2&amp;quot; | তথ্যছক&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;iupac_name&amp;#039;&amp;#039;&amp;#039; || &amp;#039;&amp;#039;N&amp;#039;&amp;#039;-[(2&amp;#039;&amp;#039;S&amp;#039;&amp;#039;)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-hexyl-1&amp;#039;&amp;#039;H&amp;#039;&amp;#039;-indazole-3-carboxamide&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;pregnancy_au&amp;#039;&amp;#039;&amp;#039; || &amp;lt;!-- A / B1 / B2 / B3 / C / D / X --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;pregnancy_us&amp;#039;&amp;#039;&amp;#039; || &amp;lt;!-- A / B            / C / D / X --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;legal_au&amp;#039;&amp;#039;&amp;#039; || &amp;lt;!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;legal_ca&amp;#039;&amp;#039;&amp;#039; || Schedule II&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;legal_de&amp;#039;&amp;#039;&amp;#039; || NpSG&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;legal_uk&amp;#039;&amp;#039;&amp;#039; || Class B&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;legal_us&amp;#039;&amp;#039;&amp;#039; || Schedule I&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;routes_of_administration&amp;#039;&amp;#039;&amp;#039; || &amp;lt;!--Pharmacokinetic data--&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;excretion&amp;#039;&amp;#039;&amp;#039; || &amp;lt;!--Identifiers--&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;cas_number_ref&amp;#039;&amp;#039;&amp;#039; || ??&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;cas_number&amp;#039;&amp;#039;&amp;#039; || 3047777-38-5&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;unii_ref&amp;#039;&amp;#039;&amp;#039; || FDA&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;pubchem&amp;#039;&amp;#039;&amp;#039; || 163191674&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;chemspiderid&amp;#039;&amp;#039;&amp;#039; || 109107958&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;smiles&amp;#039;&amp;#039;&amp;#039; || O=C(N[C@@H](C(C)(C)C)C(N)=O)C1=NN(CCCCCC)C2=C1C=CC=C2&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;stdinchi&amp;#039;&amp;#039;&amp;#039; || 1S/C20H30N4O2/c1-5-6-7-10-13-24-15-12-9-8-11-14(15)16(23-24)19(26)22-17(18(21)25)20(2,3)4/h8-9,11-12,17H,5-7,10,13H2,1-4H3,(H2,21,25)(H,22,26)/t17-/m1/s1&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;stdinchikey&amp;#039;&amp;#039;&amp;#039; || PZMLDAGKYPJWHJ-QGZVFWFLSA-N&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Chemical data--&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;c&amp;#039;&amp;#039;&amp;#039; || 20&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;h&amp;#039;&amp;#039;&amp;#039; || 30&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;n&amp;#039;&amp;#039;&amp;#039; || 4&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;o&amp;#039;&amp;#039;&amp;#039; || 2&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;ADB-HEXINACA&amp;#039;&amp;#039;&amp;#039; (যা &amp;#039;&amp;#039;&amp;#039;ADB-HINACA&amp;#039;&amp;#039;&amp;#039; এবং &amp;#039;&amp;#039;&amp;#039;ADMB-HEXINACA&amp;#039;&amp;#039;&amp;#039; নামেও পরিচিত) হলো একটি [[ক্যানাবিনয়েড|ক্যানাবিনয়েড]] ডিজাইনার ড্রাগ (designer drug), যা কিছু সিন্থেটিক ক্যানাবিস পণ্যের উপাদান হিসেবে পাওয়া গেছে। এটি প্রথম ২০২১ সালের শুরুর দিকে শনাক্ত হয়। এটি [[wikipedia:ADB-BUTINACA|ADB-BUTINACA]] এবং [[ADB-PINACA|ADB-PINACA]]-এর মতো পূর্বে পরিচিত সিন্থেটিক ক্যানাবিনয়েড যৌগগুলোর একটি দীর্ঘ শৃঙ্খলবিশিষ্ট [[wikipedia:Homologous series|সমগোত্রীয়]] (homologue) যৌগ।&amp;lt;ref&amp;gt;(November 2021). [https://discovery.dundee.ac.uk/en/publications/a9c83a12-49d4-4b09-8f08-83bac57bcc24 The metabolism of the synthetic cannabinoids ADB-BUTINACA and ADB-4en-PINACA and their detection in forensic toxicology casework and infused papers seized in prisons]. &amp;#039;&amp;#039;Drug Testing and Analysis&amp;#039;&amp;#039;. 14 (4) 634–652. doi:[https://doi.org/10.1002/dta.3203 10.1002/dta.3203].&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;(December 2021). [https://e-space.mmu.ac.uk/628354/3/Gilbert_ADBHINACA_R2.pdf Synthesis, characterisation, detection and quantification of a novel hexyl-substituted synthetic cannabinoid receptor agonist: (S)-N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-hexyl-1H-indazole-3-carboxamide (ADB-HINACA).]. &amp;#039;&amp;#039;Forensic Chemistry&amp;#039;&amp;#039;. 26. doi:[https://doi.org/10.1016/j.forc.2021.100354 10.1016/j.forc.2021.100354].&amp;lt;/ref&amp;gt; CB1 এবং CB2 রিসেপ্টরে ADB-HEXINACA এবং এর অসংখ্য অ্যানালগের ফার্মাকোলজি সম্পর্কে প্রতিবেদন প্রকাশিত হয়েছে।&amp;lt;ref&amp;gt;(April 2024). [https://pubs.acs.org/doi/10.1021/acschemneuro.3c00818 Synthesis and Functional Evaluation of Synthetic Cannabinoid Receptor Agonists Related to ADB-HEXINACA]. &amp;#039;&amp;#039;ACS Chemical Neuroscience&amp;#039;&amp;#039;. 15 (9) 1787–1812. doi:[https://doi.org/10.1021/acschemneuro.3c00818 10.1021/acschemneuro.3c00818].&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== আরও দেখুন ==&lt;br /&gt;
* [[wikipedia:4F-ADB|4F-ADB]]&lt;br /&gt;
* [[wikipedia:5F-ADB-PINACA|5F-ADB-PINACA]]&lt;br /&gt;
* [[ADB-CHMINACA|ADB-CHMINACA]]&lt;br /&gt;
* [[ADB-FUBINACA|ADB-FUBINACA]]&lt;br /&gt;
* [[wikipedia:ADB-4en-PINACA|ADB-4en-PINACA]]&lt;br /&gt;
* [[JWH-019|JWH-019]]&lt;br /&gt;
&lt;br /&gt;
== তথ্যসূত্র ==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&amp;#039;&amp;#039;উৎস:&amp;#039;&amp;#039; ইংরেজি উইকিপিডিয়ার “ADB-HEXINACA” নিবন্ধের অনুবাদ।&lt;br /&gt;
&amp;#039;&amp;#039;মূল নিবন্ধ:&amp;#039;&amp;#039; https://en.wikipedia.org/wiki/ADB-HEXINACA&lt;br /&gt;
&amp;#039;&amp;#039;এই অনুবাদটি স্বয়ংক্রিয়ভাবে প্রস্তুত করা হয়েছে।&amp;#039;&amp;#039;&lt;/div&gt;</summary>
		<author><name>Digantasen</name></author>
	</entry>
</feed>